These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30074510)

  • 41. Exploring challenges in the management and treatment of inclusion body myositis.
    Skolka MP; Naddaf E
    Curr Opin Rheumatol; 2023 Nov; 35(6):404-413. PubMed ID: 37503813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteomic analysis of inclusion body myositis.
    Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features.
    Quartuccio L; De Marchi G; Scott CA; Ferraccioli G; Beltrami CA; De Vita S
    Clin Exp Rheumatol; 2007; 25(2):246-51. PubMed ID: 17543149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dermatomyositis. Diagnosis and evaluation of dermatomyositis, polymyositis, and inclusion-body myositis.
    Krajnc I
    Adv Exp Med Biol; 1999; 455():181-6. PubMed ID: 10599341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis.
    Ray A; Amato AA; Bradshaw EM; Felice KJ; DiCapua DB; Goldstein JM; Lundberg IE; Nowak RJ; Ploegh HL; Spooner E; Wu Q; Willis SN; O'Connor KC
    PLoS One; 2012; 7(10):e46709. PubMed ID: 23071619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial inflammatory inclusion body myositis.
    Ranque-Francois B; Maisonobe T; Dion E; Piette JC; Chauveheid MP; Amoura Z; Papo T
    Ann Rheum Dis; 2005 Apr; 64(4):634-7. PubMed ID: 15769920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis.
    Sekul EA; Chow C; Dalakas MC
    Neurology; 1997 Apr; 48(4):863-6. PubMed ID: 9109868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma cells in muscle in inclusion body myositis and polymyositis.
    Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
    Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis.
    Askanas V; Engel WK
    Curr Opin Rheumatol; 1998 Nov; 10(6):530-42. PubMed ID: 9812213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
    Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
    Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Positive Cytosolic 5-Nucleotidase 1A Antibodies in Motor Neuron Disease.
    Assadi RK; Manousakis G
    J Clin Neuromuscul Dis; 2020 Sep; 22(1):50-52. PubMed ID: 32833724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment.
    Needham M; Mastaglia FL
    Clin Neurophysiol; 2016 Mar; 127(3):1764-73. PubMed ID: 26778717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intramuscular dissociation of echogenicity in the triceps surae characterizes sporadic inclusion body myositis.
    Nodera H; Takamatsu N; Matsui N; Mori A; Terasawa Y; Shimatani Y; Osaki Y; Maruyama K; Izumi Y; Kaji R
    Eur J Neurol; 2016 Mar; 23(3):588-96. PubMed ID: 26706399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fist sign in inclusion body myositis.
    Kobayashi Z; Fukatsu E; Itaya S; Akaza M; Ota K; Numasawa Y; Ishibashi S; Tomimitsu H; Shintani S
    Neuromuscul Disord; 2017 Apr; 27(4):385-386. PubMed ID: 28215761
    [No Abstract]   [Full Text] [Related]  

  • 56. Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): a population control study.
    Rojana-Udomsart A; Bundell C; James I; Castley A; Martinez P; Christiansen F; Hollingsworth P; Mastaglia F
    J Neuroimmunol; 2012 Aug; 249(1-2):66-70. PubMed ID: 22554526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current status of clinical outcome measures in inclusion body myositis: a systematised review.
    Roy B; Lucchini M; Lilleker JB; Goyal NA; Naddaf E; Adler B; Alfano LN; Malandraki GA; Focht Garand KL; Mochel D; Badrising U; Machado PM; Pagkatipunan R; Ramdharry G; Wang L; Funaro MC; Schmidt J; Kushlaf H; Schiopu E; Stipancic K; Goyal N; d'Alessandro M; Conticini E; Cruz-Coble B; Lloyd TE;
    Clin Exp Rheumatol; 2023 Mar; 41(2):370-378. PubMed ID: 36762744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
    Mastaglia FL; Garlepp MJ; Phillips BA; Zilko PJ
    Muscle Nerve; 2003 Apr; 27(4):407-25. PubMed ID: 12661042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N; Engel AG
    Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B
    Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.